Phase 1, First-in-Human Study of MEDI2228, a BCMA-Targeted ADC in Patients with Relapsed/Refractory Multiple Myeloma
Leukemia & lymphoma(2024)
关键词
Antibody drug conjugate,B-cell maturation antigen,triple refractory multiple myeloma
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要